Multi-effects of novel oral anticoagurants in nonvalvular atrial fibrillation study

Multi-effects of novel oral anticoagurants in nonvalvular atrial fibrillation study - MELODY

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000010494

Enrollment

Registered

2013-04-15

Start date

2013-04-15

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nonvalvular Atrial Fibrillation

Interventions

administration of dabigatran administration of rivaroxaban

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Nonvalvular Atrial Fibrillation

Exclusion criteria

Exclusion criteria: Valvular Atrial Fibrillation

Design outcomes

Primary

Measure	Time frame
the antiarteriosclerotic effcts	—

Countries

Japan

Contacts

Public ContactShusuke Yagi

The University of Tokushima Graduate School of Health Biosciences Department of Cardiovascular Medicine

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026